Skip to content

Investigator

Julie H Coleman

CELDARA MEDICAL, LLC · funded by NINDS, NIA

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$583k

Summed across those awards.

First award
Aug 1, 2022

Latest Sep 20, 2023.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Kv2.1-Targeted First in Class Neuroprotective Therapeutic for Acute Ischemic Stroke

    $421k

    Sep 20, 2023NINDSCELDARA MEDICAL, LLCNIH RePORTER · 10932426 (opens the source filing in a new tab)

  2. R25

    Alzheimer's-focused Celdara Medical High-Potential Entrepreneurial Fellowship Program (A-CHEF)

    $162k

    Aug 1, 2022NIACELDARA MEDICAL, LLCNIH RePORTER · 11164808 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources